Browsing Tag
Alnylam Pharmaceuticals
15 posts
Skechers, BioCryst, FTAI Aviation lead U.S. stock gainers as investors shift focus to sector-specific catalysts
See which U.S. stocks surged on May 5, 2025, and why gold, biotech, and aviation names like Skechers, BioCryst, and FTAI Aviation outperformed the market.
Vutrisiran : Alnylam Pharmaceuticals reveals positive results from HELIOS-B Phase 3 study
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a pioneer in RNA interference (RNAi) therapeutics, has unveiled promising results from the…
Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial
Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their…
Alnylam, Dicerna form RNAi collaboration for alpha-1 liver disease
Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are joining forces to develop and commercialize ribonucleicacid interference therapies (RNAi therapeutics) for…
Alnylam Pharmaceuticals completes patient enrollment for Phase 3 trial of givosiran in acute hepatic porphyrias
Alnylam Pharmaceuticals has announced the completion of patient enrollment for its pivotal phase 3 trial, ENVISION, which evaluates…